Eagle Pharmaceuticals, Inc. Derivative Liability, Current
Eagle Pharmaceuticals, Inc. had Derivative Liability, Current of $4.06 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2022-11-09
- 2022-09-30: Derivative Liability, Current $4.06M.
- 2021-12-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2022-09-30 | $4.06M 10-Q · filed 2022-11-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 |